The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.
Holders of the common stock of record at the close of business as of 8 November 2019 will receive the dividend payment on 2 December 2019.
According to the company, the fourth-quarter 2019 cash dividend will be its 324th consecutive quarterly dividend.
Pfizer said it works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time through collaborations with health care providers, governments and local communities.
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025